Cargando…

The Detection of Stem-Like Circulating Tumor Cells Could Increase the Clinical Applicability of Liquid Biopsy in Ovarian Cancer

Stem properties allow circulating tumor cells (CTCs) to survive in the bloodstream and initiate cancer progression. We aimed to assess the numbers of stem-like CTCs in patients with ovarian cancer (OC) before treatment and during first-line chemotherapy (CT). Flow cytometry was performed (Cytoflex S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gening, Snezhanna O., Abakumova, Tatyana V., Gafurbaeva, Dina U., Rizvanov, Albert A., Antoneeva, Inna I., Miftakhova, Regina R., Peskov, Andrey B., Gening, Tatyana P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401116/ https://www.ncbi.nlm.nih.gov/pubmed/34440558 http://dx.doi.org/10.3390/life11080815

Ejemplares similares

Adipose-Derived Mesenchymal Stem Cell (MSC) Immortalization by Modulation of hTERT and TP53 Expression Levels
por: Rakhmatullina, Aigul R., et al.
Publicado: (2023)

Afebrile chemotherapy-induced neutropenia: an international survey spots oncologists’ routine clinical practice versus the standard of care and the impact of COVID-19
por: Saad, Ereny Samwel Poles, et al.
Publicado: (2022)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
por: Mirgayazova, Regina, et al.
Publicado: (2020)

Recent Advances in Liquid Biopsy Based on Circulating Tumor DNA
por: Sakuma, Yu, et al.
Publicado: (2019)

Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
por: Titov, Aleksei, et al.
Publicado: (2020)

Differential expression and functional analysis of lung cancer gene expression datasets: A systems biology perspective
por: Bao, Minwei, et al.
Publicado: (2019)

Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study
por: Li, Zhao, et al.
Publicado: (2021)

Unravelling the Therapeutic Potential of Antibiotics in Hypoxia in a Breast Cancer MCF-7 Cell Line Model
por: Akhunzianov, Almaz A., et al.
Publicado: (2023)

Circulating tumor cells and DNA as liquid biopsies
por: Heitzer, Ellen, et al.
Publicado: (2013)

Circulating Long Non-Coding RNAs Could Be the Potential Prognostic Biomarker for Liquid Biopsy for the Clinical Management of Oral Squamous Cell Carcinoma
por: Dey Ghosh, Ruma, et al.
Publicado: (2022)

Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors
por: Bulatov, Emil, et al.
Publicado: (2018)

Circulating platelets as liquid biopsy sources for cancer detection
por: Antunes‐Ferreira, Mafalda, et al.
Publicado: (2020)

Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression
por: Chang, Lei, et al.
Publicado: (2019)

Two cases of carina resection for bronchogenic tumor with lung parenchyma sparing: A brief report
por: Aramini, Beatrice, et al.
Publicado: (2019)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Potential clinical utility of liquid biopsies in ovarian cancer
por: Zhu, Jie Wei, et al.
Publicado: (2022)

Adoptive Immunotherapy beyond CAR T-Cells
por: Titov, Aleksei, et al.
Publicado: (2021)

Knowns and Unknowns about CAR-T Cell Dysfunction
por: Titov, Aleksei, et al.
Publicado: (2022)

Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer
por: Hu, Wenwei, et al.
Publicado: (2017)

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
por: Yin, Chang-Qing, et al.
Publicado: (2016)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
por: Takizawa, Satoko, et al.
Publicado: (2022)

Laser transfer for circulating tumor cell isolation in liquid biopsy
por: Molpeceres, Carlos, et al.
Publicado: (2023)

Programmed cell death and its role in inflammation
por: Yang, Yong, et al.
Publicado: (2015)

An integrated analysis of the effects of microRNA and mRNA on esophageal squamous cell carcinoma
por: YANG, YONG, et al.
Publicado: (2015)

Pulmonary artery pseudoaneurysm after a left upper sleeve lobectomy
por: Bao, Minwei, et al.
Publicado: (2013)

Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective
por: Dai, Jie, et al.
Publicado: (2017)

Uniportal video‐assisted thoracoscopic left S4 anatomical segmentectomy
por: Song, Nan, et al.
Publicado: (2019)

Different driver gene mutations in patients with synchronous multiple primary lung cancers: a case report
por: Yang, Yong, et al.
Publicado: (2020)

Use of an autologous dermal flap and rib cartilage graft in the repair of a large tracheoesophageal fistula with tracheal stenosis
por: Dai, Jie, et al.
Publicado: (2023)

Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer
por: Gahlawat, Aoife Ward, et al.
Publicado: (2023)

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
por: Cheng, Feifei, et al.
Publicado: (2016)

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
por: Larrea, Erika, et al.
Publicado: (2016)

Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer
por: Grunvald, Miles W., et al.
Publicado: (2020)

Identification and validation of circulating exosomes‐based liquid biopsy for esophageal cancer
por: Zhao, An, et al.
Publicado: (2019)

Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions
por: Gattuso, Giuseppe, et al.
Publicado: (2022)

Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy
por: Roi, Alexandra, et al.
Publicado: (2023)

Aptamers: Problems, Solutions and Prospects
por: Lakhin, A.V., et al.
Publicado: (2013)

An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bmp5ko6vl2uvs6ahah53kl86ti